PedAM
Pediatric Disease Annotations & Medicines
| Disease | myocardial infarction |
| Phenotype | C0027051|myocardial infarct |
| Sentences | 5 |
| PubMedID- 24634292 | Association of plasma b-type natriuretic peptide concentration with myocardial infarct size in patients with acute myocardial infarction. |
| PubMedID- 25488040 | The impact of processes of care on myocardial infarct size in patients with st-segment elevation myocardial infarction: observations from the crisp-ami trial. |
| PubMedID- 19409628 | In order to weigh the current evidence linking poc to reduction of myocardial infarct size in patients with st-segment elevation myocardial infarction (stemi) undergoing primary percutaneous coronary intervention (ppci), we performed a systematic review and meta-analysis of the available data from small randomised trials. |
| PubMedID- 23364453 | It has been shown that administration of glp-1 at the time of reperfusion was effective in decreasing myocardial infarct size in patients with acute myocardial infarction (8). |
| PubMedID- 25511098 | Conclusions: our results demonstrate that ghrelin could improve microvascular density, cardiac function, and reduce myocardial infarct size of diabetic rats with myocardial infarction via modulating ghsr1a-mediated expressions of vegf, flk-1 and flt-1. |
Page: 1